Synthesis of 2 g of 4-amino-n-(2,4-difluorobenzyl)-1-hydroxy-6-(hydroxymethyl)-2-OXO-1,2-dihydro-1,8-naphthyridine-3-carboxamide (XZ426).

Ended Awarded Mar 28, 2019 Last action Jan 8, 2020

Contract number: 75N91019F00129
Awardee: Alchem Laboratories Corporation UEI LD2KY6H7KMQ5
Awarding agency: National Cancer Institute National Institutes of Health, Department of Health and Human Services
Obligated: $23,283

Award facts

Opportunity: N02CM7700018 Solicitation number

Synthesis of Non-GMP Small Molecules Award Notice · Posted Sep 14, 2017

Synthesis of Non-GMP Small Molecules Award Notice · Posted Nov 23, 2016
Contract value 100% obligated: $23,283.44 Current and potential, with all options
Completion date 100% complete: Jun 7, 2019 Current and potential, with all options
NAICS code: 325412 Pharmaceutical Preparation Manufacturing
PSC: B599 Special Studies/Analysis- Other
Set-aside: No set-aside
Competition: Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
Pricing: Cost Plus Fixed Fee
Place of performance: Santa Fe, FL 32615, USA
Legislative mandates: Service Contract Inventory FAR subpart 4.17

Award details come from SAM.gov/FPDS.

Action	Obligated	Date
Close Out P00002	-$6	Jan 8, 2020
Other Administrative Action P00001	$0	May 30, 2019
Original award	$23,289	Mar 28, 2019

75N91019F00129 was awarded to Alchem Laboratories Corporation by National Cancer Institute (National Institutes of Health) on March 28, 2019.

The government has obligated $23,283 on 75N91019F00129.

Yes. 75N91019F00129 is a delivery order under HHSN261201700007I, an indefinite delivery contract.

The extent of competition for 75N91019F00129 was full and open competition after exclusion of sources.

On GovTribe

Try for free Login